You searched for "Future"

707 results found

Preime DermaFacial: the world’s most advanced aesthetic facial device

Preime is a cutting-edge innovation in skincare technology, designed to deliver comprehensive facial treatments tailored to individual needs.

Facial contouring with fillers

With the advent of hyaluronic acid fillers, safe and effective non-surgical facial rejuvenation has been advanced. Hyaluronic acid fillers are becoming increasingly popular amongst patient who seek facial enhancement. In 2013, there were over 1.8 million treatments using hyaluronic acid...

Using erythema-directed digital photography in patients with rosacea

The authors, from the University of Catania in Italy, discuss the promise that erythema-directed digital photography is showing in the clinical evaluation and targeted treatment of rosacea. Rosacea is a common chronic inflammatory facial condition that can lead to significant...

The gender affirmation surgery MDT

The authors provide a comprehensive and thought-provoking discussion of the multidisciplinary nature of caring for someone undergoing gender reassignment surgery. In the last 50 years in the UK an estimated 130,000 people have changed their gender assigned at birth (assigned...

Lips and the perioral area: anatomical considerations for safer and natural results

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Minimally invasive cosmetic procedures, including lip augmentation using hyaluronic acid dermal fillers,...

How I Do It - Two-Point Eye Lift™: HA dermal fillers for infraorbital rejuvenation

The key to maintaining a youthful appearance is often found in restoring a well-defined periorbital area, characterised by healthy tissue volume (fullness) in the infraorbital region and a clear eyelid crease devoid of excess skin. The use of hyaluronic acid...

Aesthetic restoration following GLP-1 agonist–induced facial volume loss

GLP-1 receptor agonists such as semaglutide (Ozempic®, Wegovy®, Rybelsus®) have significantly improved the management of obesity and type 2 diabetes, providing effective weight loss and cardiometabolic benefits. However, as their use becomes more widespread, there has been an increase in...

Peeling away the years: bespoke framework technique for using Definisse™ Peel Program from RELIFE in acne

Acne vulgaris is the most common potentially scarring skin condition seen in dermatology and general practice. A recent network metanalysis [1] confirmed the efficacy of oral pharmacological therapies but questioned the consistency of effect of topical agents and peels. Factors...

How I Do It - A novel method obviating the need to proceed to second stage autologous skin grafting in selected burned patients resurfaced with Integra™

A survivor of large full thickness skin burns will have suffered for months during repeated grafting surgeries to heal, yet real recovery will take years, if at all, because of the inevitable physical and mental challenges. Time spent on the...

Facial veins – diagnosis and treatment options

Facial veins can be treated with a wide range of aesthetic and surgical procedures. Victoria Smith and Professor Mark Whiteley, both experts in the area, provide a comprehensive overview of diagnosis and the different treatment options available. Patients with unwanted...

Immediate versus delayed post mastectomy breast reconstruction

The authors review and analyse the current literature comparing the psychosocial outcomes of immediate versus delayed post mastectomy breast reconstruction. Breast cancer is the most prevalent cancer in women and has a lifetime incidence of one in nine. Mastectomy may...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...